Abstract:BACKGROUND:Combretastatin A-4 (CA-4) is a natural product isolated from the bark of the South African bush willow tree Combretum caffrum, which exerts tubulin inhibition, but its clinical application is limited due to poor stability and water solubility. 2-aryl benzimidazoles are excellent pharmacological skeletons with many activities, especially in tumor inhibition, and better pharmacokinetic properties. Several scaffold CA-4 analogs have been synthesized to date possessing antitumor activities.OBJECTIVE:The benzimidazole was applied as the core moiety to replace the B ring and unstable linkage of CA-4, and the 5-aryl acetenyl group was introduced to improve the antitumor activity. MCF-7, A549, Caco-2, Siha, and Eca-109 tumor cell lines were used to study inhibition by these agents in vitro.METHODS:The benzimidazole structure was constructed from the oxidation of o-nitroaniline and aldehyde and the following schemes, and the structural characterization was carried out. The antitumor effects were evaluated in vitro through MTT assay, cell cycle arrest, and apoptosis assay. Molecular docking with tubulin (Protein ID: 1SA0) was analyzed for the structure-activity relationship.RESULTS:Among these derivatives, 4a-4h series (with 6-methoxy group) compounds inhibited the tumor cell lines much stronger than the CA-4 and cisplatin, especially compound 4f showed prominently inhibitory activity in Siha cell with IC50 value as 0.61 μmol/L. The further assay showed that the cell cycle was arrested at the G0/G1 phase as well verified in apoptosis assay. Molecular docking indicated that 4f had stronger affinity energy and hydrogen bond than CA-4.CONCLUSION:The compound 4f has the potency to be used as an anti-tubulin agent and the 2-trimethoxyphenyl benzimidazole skeleton deserves further study as an antitumor structure.

Concise Synthesis and Antitumor Activity of Bengamide E and Its Analogs

Synthesis, Biological Evaluation and Docking Studies of (E)-3-Aryl-2-(3,4,5-trimethoxybenzoyl) Acrylonitrile Derivatives as Anticancer Agents

Synthesis of N-Substituted Benzamide Derivatives and Their Evaluation As Antitumor Agents

Design, Synthesis, and Anti-tumor Activity of Novel 2-Aryl Benzimidazole Compounds.

Synthesis And Biological Evaluation Of Novel Acenaphthene Derivatives As Potential Antitumor Agents

Design, Synthesis, Antitumor Activity Evaluation, and Molecular Dynamics Simulation of Some 2-Aminopyrazine Derivatives

Design, Synthesis, And Biological Evaluation Of Ring-Opened Bengamide Analogues

Total Synthesis of 4-epi-Bengamide E

Synthesis and Antitumor Activities of Novel 20(S)-O-Linked Substituted Benzoic Acid-7-Benzoylcamptothecin Esters

Design, synthesis and biological evaluation of tryptamine salicylic acid derivatives as potential antitumor agents.

Design, Synthesis, and Antitumor Activity of Β-Carboline- Benzimidazole Hybrids

Structural Modification and Inhibitory Activity on Tumor Cell Proliferation of Novel Diaryl-β-lactam Compounds As Tubulin Aggregation Inhibitors

Synthesis and Biological Evaluation of Novel 1-Aryl, 5(Phenoxy-Substituted)aryl-1,4-pentadien-3-one Derivatives

Anticancer Activity of New Compounds Using Benzimidazole as a Scaffold

Synthesis and Antitumor Evaluation of Novel 5-Hydrosulfonyl-1h-benzo[d]imidazol-2(3h)-one Derivatives.

Discovery of Novel Heteroarylmethylcarbamodithioates As Potent Anticancer Agents: Synthesis, Structure-Activity Relationship Analysis and Biological Evaluation.

Synthesis And Biological Evaluation Of Novel Benzothiazole-2-Thiol Derivatives As Potential Anticancer Agents

[Design, Synthesis and Antitumor Activities of Novel E-substituted 2,3-Diaryl Propenoic Acyloxy Phosphonate Derivatives].

Synthesis and antitumor activity of simplified ecteinascidin-saframycin analogs.

Design, Synthesis and Biological Evaluation of 2-Phenoxy-N-Phenylacetamides as Novel Anticancer Agents

Synthesis and antitumor activity of 17-carboxylic acid modified amide derivatives of 23-hydroxy betulinic acid